SCHEMBL5221426

SCHEMBL5221426

CNc1cc(C(=O)OC(C)(C)C)cc(N2CCCCC2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.42
ALDH1A1 P00352 4/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
F10 P00742 7/20 0.39
MAPT P10636 1/20 0.38
ATM Q13315 1/20 0.37
SRD5A1 P18405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5220621 0.96 MEN1 (0.48) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL5219406 0.87 CTSD (0.48)
SCHEMBL5224185 0.84 HPGD (0.43) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL5222334 0.84 CTSD (0.51)
SCHEMBL5223595 0.84 ALDH1A1 (0.55) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL5219080 0.83 HPGD (0.42) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL5218821 0.83 HPGD (0.42) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL5221158 0.83 MEN1 (0.48) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL5218227 0.81 ALDH1A1 (0.57) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL5221942 0.79 ALDH1A1 (0.44) MEN1KMT2AALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed